We are live on ! Find out more
ASMB icon

Assembly Biosciences
ASMB

49 hedge funds and large institutions have $301M invested in Assembly Biosciences in 2017 Q1 according to their latest regulatory filings, with 19 funds opening new positions, 15 increasing their positions, 7 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

850% more first-time investments, than exits

New positions opened: 19 | Existing positions closed: 2

189% more call options, than puts

Call options by funds: $5.24M | Put options by funds: $1.81M

115% more capital invested

Capital invested by funds: $140M → $301M (+$161M)

114% more repeat investments, than reductions

Existing positions increased: 15 | Existing positions reduced: 7

36% more funds holding

Funds holding: 36 → 49 (+13)

0.11% more ownership

Funds ownership: 5.64% → 5.75% (+0.11%)

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

Holders
49
Holders Change
+13
Holders Change %
+36.11%
% of All Funds
1.22%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
19
Increased
15
Reduced
7
Closed
2
Calls
$5.24M
Puts
$1.81M
Net Calls
+$3.42M
Net Calls Change
+$3.91M

Top Buyers

Rank Fund Capital Flow
1
ACA
Avoro Capital Advisors
New York
+$8.71M
2
BlackRock
BlackRock
New York
+$6.59M
3
ACP
Acuta Capital Partners
California
+$2.52M
4
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$2.08M
5
Goldman Sachs
Goldman Sachs
New York
+$1.26M

Top Sellers

Rank Fund Capital Flow
1
PI
Putnam Investments
Massachusetts
-$4.43M
2
O
OrbiMed
New York
-$2.86M
3
Millennium Management
Millennium Management
New York
-$2.17M
4
QF
QVT Financial
New York
-$1.98M
5
Jennison Associates
Jennison Associates
New York
-$1.27M
Name Holding Trade Value Shares
Change 		Change in
Stake
SCM
26
Segantii Capital Management
Hong Kong
$502K +$342K +1,393 +557%
Simplex Trading
27
Simplex Trading
Illinois
$431K +$246K +1,002 +246%
PP
28
PDT Partners
New York
$367K +$294K +1,200 New
DCM
29
Dupont Capital Management
Delaware
$344K +$276K +1,126 New
Bank of New York Mellon
30
Bank of New York Mellon
New York
$310K – – –
BCM
31
BlueCrest Capital Management
Jersey
$309K +$248K +1,012 New
BRWA
32
B. Riley Wealth Advisors
Florida
$300K -$46.1K -188 -16%
California Public Employees Retirement System
33
California Public Employees Retirement System
California
$287K – – –
Acadian Asset Management
34
Acadian Asset Management
Massachusetts
$263K +$124K +506 +143%
Deutsche Bank
35
Deutsche Bank
Germany
$254K +$12.3K +50 +6%
Renaissance Technologies
36
Renaissance Technologies
New York
$242K +$194K +792 New
PPA
37
Parametric Portfolio Associates
Washington
$226K +$182K +740 New
GP
38
GLG Partners
United Kingdom
$225K +$181K +736 New
HSBC Holdings
39
HSBC Holdings
United Kingdom
$206K +$165K +674 New
Group One Trading
40
Group One Trading
Illinois
$173K +$104K +423 +298%
FPF
41
FNY Partners Fund
New York
$140K +$112K +458 New
Zurich Cantonal Bank
42
Zurich Cantonal Bank
Switzerland
$122K +$98.1K +400 New
TDC
43
Thompson Davis & Co
Virginia
$80K +$48.3K +197 +313%
UBS Group
44
UBS Group
Switzerland
$38K +$8.83K +36 +41%
AIM
45
Acrospire Investment Management
Illinois
$24K +$18.9K +77 New
Federated Hermes
46
Federated Hermes
Pennsylvania
$17K +$1.23K +5 +10%
Royal Bank of Canada
47
Royal Bank of Canada
Ontario, Canada
$8K +$6.13K +25 New
Creative Planning
48
Creative Planning
Kansas
$7K +$5.4K +22 New
Manulife (Manufacturers Life Insurance)
49
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$2K – – –
PI
50
Putnam Investments
Massachusetts
– -$4.43M -30,379 Closed
1
2
3

ASMB Hedge Fund Activity: Q1 2017 in Review

49 of the 4,017 institutional investors tracked by Wall St. Rank reported a position in Assembly Biosciences (ASMB) for Q1 2017, worth a combined $301M — up 115% from $140M a quarter earlier.

Buyers outnumbered sellers: 19 funds opened new ASMB positions and 2 closed out — a net gain of 17 holders — while 15 added to existing stakes and 7 trimmed.

The largest buyer was Avoro Capital Advisors, adding an estimated $8.71M. The largest seller was Putnam Investments, exiting entirely with an estimated $4.43M sold.

  • 49 institutional investors held Assembly Biosciences (ASMB) as of Q1 2017, up from 36 in Q4 2016.
  • Funds reported $301M of Assembly Biosciences stock for Q1 2017, up 115% quarter-over-quarter.
  • 19 funds opened new Assembly Biosciences positions in Q1 2017 and 2 closed out, a net change of +17 holders.
  • The largest Assembly Biosciences buyer in Q1 2017 was Avoro Capital Advisors, an estimated $8.71M added.
  • The largest Assembly Biosciences seller in Q1 2017 was Putnam Investments, an estimated $4.43M sold.

Based on aggregated 13F filings for Q1 2017.